Delivery Order SPE2DB22D3004-SPE2DB25FSC17
Award Date 8/21/25
Potential Completion Date 8/22/25
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Pioglitazone HCL 15 mg tablets in quantities of 90 units. This contract is a firm fixed-price delivery order with a ceiling value of $4,167.80 and an ultimate completion date of September 2, 2025. The award is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,804.19 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 45 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was executed on August 21, 2025, with an ultimate completion date of August 22, 2025, and represents a non-set-aside procurement. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,749.28 to AmerisourceBergen Drug Corp for 500 tablets of Pioglitazone HCL 30 mg, with an ultimate completion date of July 23, 2025. This competitive, non-set-aside contract was awarded on July 22, 2025, with firm fixed pricing and performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.86 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 45 mg tablets (90-count) on August 21, 2025, with an ultimate completion date of August 22, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,504.46 to AmerisourceBergen Drug Corp for 500 tablets of Pioglitazone HCL 30 mg, a diabetes management medication. The contract, awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, is structured as a firm fixed price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,498.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Pioglitazone HCL 30 mg tablets (90-count units). This non-set-aside contract is scheduled for completion by September 10, 2025, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Pioglitazone HCL 30 mg tablets. The contract, valued at $1,186.51, has an ultimate completion date of April 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Pioglitazone HCL 45 mg tablets in quantities of 500 units, with a ceiling value of $1,010.78. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $2,164.64 firm fixed-price delivery order is for the supply of 90-count tablets of the diabetes medication Pioglitazone Hydrochloride 45 milligrams. The contract has a period of performance through June 30, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,669.15, is a Firm Fixed Price Delivery Order for the supply of Pioglitazone HCL 45 MG Tablets. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...